Health Dictionary Find a Doctor

Autoimmune polyendocrine syndrome MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]

Overview

Overview

Brain MRI may be helpful in the diagnosis of autoimmune polyendocrine syndrome associated hypopituitarism and hypogonadism. Findings on MRI suggestive of autoimmune polyendocrine syndrome include hypopituitarism and hypogonadism. MRI is the imaging procedure of choice in the diagnosis of hypopituitarism. It is preferred over the CT scan as optic chiasm, pituitary stalk, and cavernous sinuses can be seen in MRI. An MRI lesion needs to be related to clinical and lab findings. The absence of an MRI lesion mostly indicates a non-organic etiology. Autoantibodies against pituitary gland results in hemorrhage into the pituitary gland which presents as a high-intensity signal on both T1- and T2-weighted images.

MRI

MRI

Brain MRI may be helpful in the diagnosis of autoimmune polyendocrine syndrome associated hypopituitarism and hypogonadism. Findings on MRI suggestive of autoimmune polyendocrine syndrome include hypopituitarism and hypogonadism. MRI in autoimmune polyendocrine syndrome may present with the following features:[1][2][3][4][5][6]

  • MRI is the single best imaging modality in the evaluation of sellar masses as certain findings are suggestive of some specific sellar masses and help to differentiate them.
  • If MRI is not possible due to any reason, high-resolution CT scan with contrast administration, in coronal plane, may be used as an alternative.
  • An magnetic resonance imaging (MRI) scan may show a three-dimensional image of pituitary gland, hypothalamus, and the organs near them.
  • MRI is used to detect the underlying cause of like the pituitary adenoma that can be seen as a mass with hormonal hypersecretion.
  • There is a positive correlation between MRI findings and the number of pituitary hormonal deficiencies.
  • An MRI lesion needs to be related to clinical and lab findings. The absence of an MRI lesion mostly indicates a non-organic etiology.
References

References

  1. Vance, Mary Lee (1994). “Hypopituitarism”. New England Journal of Medicine. 330 (23): 1651–1662. doi:10.1056/NEJM199406093302306. ISSN 0028-4793.
  2. Li G, Shao P, Sun X, Wang Q, Zhang L (2010). “Magnetic resonance imaging and pituitary function in children with panhypopituitarism”. Horm Res Paediatr. 73 (3): 205–9. doi:10.1159/000284363. PMID 20197674.
  3. Child CJ, Zimmermann AG, Woodmansee WW, Green DM, Li JJ, Jung H, Erfurth EM, Robison LL (2011). “Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study”. Eur. J. Endocrinol. 165 (2): 217–23. doi:10.1530/EJE-11-0286. PMC 3132593. PMID 21646285.
  4. Pozzi Mucelli, R. S.; Frezza, F.; Magnaldi, S.; Proto, G. (1992). “Magnetic resonance imaging in patients with panhypopituitarism”. European Radiology. 2 (1): 42–46. doi:10.1007/BF00714180. ISSN 0938-7994.
  5. Imashuku S, Kudo N, Kaneda S, Kuroda H, Shiwa T, Hiraiwa T, Inagaki A, Morimoto A (2011). “Treatment of patients with hypothalamic-pituitary lesions as adult-onset Langerhans cell histiocytosis”. Int. J. Hematol. 94 (6): 556–60. doi:10.1007/s12185-011-0955-z. PMID 22015494.
  6. De Herder WW, Lamberts SW (1995). “Imaging of pituitary tumours”. Baillieres Clin. Endocrinol. Metab. 9 (2): 367–89. PMID 7625990.

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH